| CTRI Number |
CTRI/2019/02/017441 [Registered on: 05/02/2019] Trial Registered Prospectively |
| Last Modified On: |
20/11/2020 |
| Post Graduate Thesis |
Yes |
| Type of Trial |
Observational |
|
Type of Study
|
Cross Sectional Study |
| Study Design |
Single Arm Study |
|
Public Title of Study
|
Prevalence and outcome of treatment of lazy eye |
|
Scientific Title of Study
|
Prevalence of amblyopia in Children less than 18 years attending a tertiary care hospital and outcome of amblyopia therapy |
| Trial Acronym |
|
|
Secondary IDs if Any
|
| Secondary ID |
Identifier |
| NIL |
NIL |
|
|
Details of Principal Investigator or overall Trial Coordinator (multi-center study)
|
| Name |
Dr Anuj Harish Kodnani |
| Designation |
Postgraduate Resident |
| Affiliation |
Kasturba Medical College, Manipal |
| Address |
Department of Ophthalmology, Kasturba Medical College, Manipal 701, Regal Woods, Manipal Udupi KARNATAKA 576104 India |
| Phone |
9428974800 |
| Fax |
|
| Email |
anuj_kodnani@yahoo.co.in |
|
Details of Contact Person Scientific Query
|
| Name |
Dr Vijaya Pai H |
| Designation |
Professor and Head of Unit |
| Affiliation |
Kasturba Medical College, Manipal |
| Address |
Department of Ophthalmology, Kasturba Medical College, Manipal
Udupi KARNATAKA 576104 India |
| Phone |
9428974800 |
| Fax |
|
| Email |
pai.vijaya@manipal.edu |
|
Details of Contact Person Public Query
|
| Name |
Dr Vijaya Pai H |
| Designation |
Professor and Head of Unit |
| Affiliation |
Kasturba Medical College, Manipal |
| Address |
Department of Ophthalmology, Kasturba Medical College, Manipal
Udupi KARNATAKA 576104 India |
| Phone |
9428974800 |
| Fax |
|
| Email |
pai.vijaya@manipal.edu |
|
|
Source of Monetary or Material Support
|
| Kasturba Medical College, Manipal, Udupi, Karnataka - 576104 |
|
|
Primary Sponsor
|
| Name |
Dr Anuj Harish Kodnani |
| Address |
Department of Ophthalmology, Kasturba Medical College, Manipal |
| Type of Sponsor |
Other [Self] |
|
|
Details of Secondary Sponsor
|
|
|
Countries of Recruitment
|
India |
|
Sites of Study
|
| No of Sites = 1 |
| Name of Principal
Investigator |
Name of Site |
Site Address |
Phone/Fax/Email |
| Dr Anuj Harish Kodnani |
Kasturba Medical College and Hospital |
Department of Ophthalmology, Kasturba Medical College, Manipal Udupi KARNATAKA |
9428974800
anuj_kodnani@yahoo.co.in |
|
|
Details of Ethics Committee
|
| No of Ethics Committees= 1 |
| Name of Committee |
Approval Status |
| Kasturba Medical College and Kasturba Hospital Institutional Committee |
Approved |
|
|
Regulatory Clearance Status from DCGI
|
|
|
Health Condition / Problems Studied
|
| Health Type |
Condition |
| Patients |
(1) ICD-10 Condition: H530||Amblyopia ex anopsia, |
|
|
Intervention / Comparator Agent
|
|
|
Inclusion Criteria
|
| Age From |
0.00 Year(s) |
| Age To |
18.00 Year(s) |
| Gender |
Both |
| Details |
All cases of amblyopia including newly diagnosed cases as well as cases undergoing treatment of amblyopia. |
|
| ExclusionCriteria |
| Details |
1.) Children who have discontinued treatment from the hospital in between the study period or who did not have minimum follow-up of 3 months.
2.) Cases whose parents do not give consent for study.
3.) Mentally challenged patients. |
|
|
Method of Generating Random Sequence
|
Not Applicable |
|
Method of Concealment
|
Not Applicable |
|
Blinding/Masking
|
Open Label |
|
Primary Outcome
|
| Outcome |
TimePoints |
| The prevalence of amblyopia analysed by taking the numerator as the number of amblyopia cases within the target age group and the denominator as the total number of children who visited the OPD in the same age group in the thesis study period. |
same day/one day |
|
|
Secondary Outcome
|
| Outcome |
TimePoints |
| Initial visual acuity and visual acuity after 3 to 6 months of follow up. |
same day/one day |
|
|
Target Sample Size
|
Total Sample Size="50" Sample Size from India="50"
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" |
|
Phase of Trial
|
N/A |
|
Date of First Enrollment (India)
|
10/02/2019 |
| Date of Study Completion (India) |
Applicable only for Completed/Terminated trials |
| Date of First Enrollment (Global) |
Date Missing |
| Date of Study Completion (Global) |
Applicable only for Completed/Terminated trials |
|
Estimated Duration of Trial
|
Years="1" Months="8" Days="0" |
Recruitment Status of Trial (Global)
Modification(s)
|
Not Applicable |
| Recruitment Status of Trial (India) |
Closed to Recruitment of Participants |
Publication Details
Modification(s)
|
None yet |
|
Individual Participant Data (IPD) Sharing Statement
|
Will individual participant data (IPD) be shared publicly (including data dictionaries)?
|
|
Brief Summary
|
Amblyopia, the leading cause of monocular vision impairment in children, is caused by inadequate stimulation of the visual system during the sensitive periods of visual development in childhood. A difference in best corrected visual acuity of two Snellen lines or more (or more than one log unit) is indicative of amblyopia. Bilateral refractive amblyopia is defined as vision <6/12 best-corrected in the presence of ≥ +4.00D and/or ≥ 2.00D astigmatism in each eye. Strabismus, cataract and anisometropia are well known causes of amblyopia with strabismic amblyopia being the most common type. Onset of amblyopia is generally in early life typically before the age of 6 years. Treatment regimens include spectacles, patching, and/or atropine penalization.The aim is to study the prevalence of amblyopia in children less than 18 years of age and to study the outcome of patching therapy in amblyopia. All cases of amblyopia coming to the department of ophthalmology in Kasturba Hospital, Manipal on OPD basis including newly diagnosed cases as well as cases undergoing treatment of amblyopia are included in the study. The cases of amblyopia for study will be given treatment of patching which is the standard of care. Those who are willing for regular follow up and complying to the instructions will be followed up for treatment effect. Visual acuity will be noted and measured according to age appropriate method during each visit. Improvement in vision and compliance to patching will be noted. |